抗结核药物性肝损伤血清细胞因子研究
Analysis of Serum Cytokines in Antituberculosis Drug-Induced Liver Injury
DOI: 10.12677/ACM.2023.1361434, PDF,  被引量   
作者: 刘慧英:石河子大学医学院,新疆 石河子 ;左维泽*, 张 砚*, 朱庆峰:石河子大学第一附属医院感染性疾病科,新疆 石河子
关键词: 药物性肝损伤肺结核细胞因子Drug-Induced Liver Injury Pulmonary Tuberculosis Cytokines
摘要: 目的:探讨外周血IFN-γ、TNF-α及IL-10细胞因子与抗结核药物性肝损伤(ATDILI)的相关性及诊断价值。方法:纳入2022年1月至2023年1月石河子大学第一附属医院住院及门诊部诊断为初治肺结核的患者。将2个月内发生抗结核药物性肝损伤(ATDILI)患者为观察组,将完成整个2个月强化期未发生肝损伤的肺结核患者为对照组。共收入观察组23例,对照组22例。用ELISA法检测所有患者治疗前、观察组发生药物性肝损伤时、对照组抗结核治疗2个月后的外周血清细胞因子水平。结果:抗结核治疗后,观察组患者与对照组相比,IFN-γ、TNF-α及IL-10细胞因子水平均与对照组有显著差异,差异有统计学意义(P < 0.05)。IFN-γ、TNF-α及IL-10细胞因子灵敏度为73.91%、52.17%、65.22%;特异度分别为95.45%、95.45%、81.81%。结论:抗结核治疗后,IFN-γ、TNF-α、IL-10细胞因子与ATDILI有一定的相关性,可能参与了ATDILI的发生发展过程,对诊断ATDILI有一定的价值。
Abstract: Objective: To analyze the diagnostic value of and the correlation between the IFN-γ, TNF-α, IL-10 cytokines of peripheral blood and the process of anti-tuberculosis drug induced liver injury (ATDILI). Methods: Patients diagnosed with newly diagnosed pulmonary tuberculosis in the inpa-tient and outpatient departments of the First Affiliated Hospital of Shihezi University Medical Col-lege from January 2022 to January 2023 were included. The patients with anti-tuberculosis drug-induced liver injury (ATDILI) within 2 months were selected as the observation group, and the patients with pulmonary tuberculosis who completed the whole 2-month intensive an-ti-tuberculosis process without liver injury were selected as the control group. There were 23 cases in observation group and 22 cases in control group. The peripheral blood immune cell levels of all patients were tested before treatment, during drug-induced liver injury in the observation group, and 2 months after anti-tuberculosis treatment in the control group measured by ELISA. Results: After anti-tuberculosis treatment, in the observation group, compared with the control group, IFN-γ, TNF-α, IL-10 cytokine levels were significantly higher than the control group, and the difference was statistically significant (P < 0.05). The sensitivity of IFN-γ, TNF-α and IL-10 was 73.91%, 52.17% and 65.22%; the specificity was 95.45%, 95.45% and 81.81%. Conclusion: After anti-tuberculosis treatment, IFN-γ, TNF-α, and IL-10 cytokines were related with ATDILI, which may participate in the development of ATDILI, and have certain value in the diagnosis of ATDILI.
文章引用:刘慧英, 左维泽, 张砚, 朱庆峰. 抗结核药物性肝损伤血清细胞因子研究[J]. 临床医学进展, 2023, 13(6): 10248-10254. https://doi.org/10.12677/ACM.2023.1361434

参考文献

[1] 张培元. 肺结核诊断和治疗指南[J]. 中华结核和呼吸杂志, 2001, 24(2): 70-74.
[2] 中华人民共和国国家卫生和计划生育委员会. 肺结核诊断标准(WS288-2017) [J]. 新发传染病电子杂志, 2018, 3(1): 59-61. [Google Scholar] [CrossRef
[3] Wang, N.N., Chen, X.Y., Hao, Z.L., Guo, J., Wang, X.W., Zhu, X.J., Yi, H.G., Wang, Q.L. and Tang, S.W. (2022) Incidence and Temporal Trend of Antituberculosis Drug-Induced Liver Injury: A Systematic Review and Meta-Analysis. Journal of Tropical Medicine, 2022, Article ID: 8266878. [Google Scholar] [CrossRef] [PubMed]
[4] 黄家辉, 叶旻泓, 周欣. 抗结核药物导致肝损害2015-2020年文献分析[J]. 现代药物与临床, 2021, 36(4): 823-827.
[5] Zhang, T., Du, J., Yin, X., et al. (2015) Ad-verse Events in Treating Smear-Positive Tuberculosis Patients in China. Multidisciplinary Digital Publishing Institute, 13, Article 86. [Google Scholar] [CrossRef] [PubMed]
[6] 中华医学会结核病学分会. 抗结核药物性肝损伤诊治指南(2019年版) [J]. 中华结核和呼吸杂志, 2019, 42(5): 343-356.
[7] 孙勤, 孙雯雯, 沙巍, 等. 抗结核药物所致肝损伤的危险因素及其对结核病患者治疗结局影响的回顾性队列研究[J]. 中华传染病杂志, 2015, 33(12): 725-730.
[8] European Association for the Study of the Liver (2019) EASL Clinical Practice Guidelines: Drug-Induced Liver Injury. Journal of Hepatology, 70, 1222-1261.
[9] Wang, X.Z., Xue, R.F., Zhang, S.Y., Zheng, Y.T., Zhang, L.Y. and Jiang, Z.Z. (2018) Activation of Natural Killer T Cells Contributes to Triptolide-Induced Liver In-jury in Mice. Acta Pharmacologica Sinica, 39, 1847-1854. [Google Scholar] [CrossRef] [PubMed]
[10] 杨雪, 涂荣芳, 杨晋辉. 药物性肝损伤的研究进展[J]. 临床肝胆病杂志, 2020, 36(3): 509-513.
[11] Garcia-Cortes, M., Robles-Diaz, M., Stephens, C., Ortega-Alonso, A., Lucena, M.I. and Andrade, R.J. (2020) Drug Induced Liver Injury: An Update. Archives of Toxicology, 94, 3381-3407. [Google Scholar] [CrossRef] [PubMed]
[12] Singh, I.K. and Sharma, P. (2022) An Interplay of Cellular and Molecular Components of Immunology. CRC Press, Boca Raton.
[13] Chauhan, P., Nair, A., Patidar, A., et al. (2021) A Primer on Cytokines. Cytokine, 145, Article ID: 155458. [Google Scholar] [CrossRef] [PubMed]
[14] Roth, R.A., Maiuri, A.R. and Ganey, P.E. (2017) Idiosyncratic Drug-Induced Liver Injury: Is Drug-Cytokine Interaction the Linchpin? The Journal of Pharmacology and Experimental Therapeutics, 360, 368-377. [Google Scholar] [CrossRef] [PubMed]
[15] 吴于青, 孙琦, 邓国防. 抗结核药物性肝炎患者外周血IFN-γ、IL-10的水平分析[J]. 实用医学杂志, 2012, 28(4): 605-607.
[16] 吴怡玲, 邓国防. 抗结核药物性肝炎患者血清IL-10与IFN-γ水平的变化及意义[J]. 实用临床医学, 2013, 14(11): 15-16, 18.
[17] 赵善民. 肿瘤坏死因子—α在不同类型肝损伤中的作用及机制研究[D]: [博士学位论文]. 上海: 中国人民解放军海军军医大学, 2019.
[18] Gandhi, A., Guo, T. and Ghose, R. (2010) Role of c-Jun N-Terminal Kinase (JNK) in Regulating Tumor Necrosis Factor-α (TNF-α) Mediated Increase of Acetaminophen (APAP) and Chlorpromazine (CPZ) Toxicity in Murine Hepatocytes. Journal of Toxicological Sciences, 35, 163-173. [Google Scholar] [CrossRef] [PubMed]
[19] Masson, M.J., Collins, L.A. and Pohl, L.R. (2010) The Role of Cytokines in the Mechanism of Adverse Drug Reactions. In: Uetrecht, J., Ed., Adverse Drug Reactions. Handbook of Experimental Pharmacology, Springer, Berlin, 195-231. [Google Scholar] [CrossRef] [PubMed]
[20] Blaser, H., Dostert, C., Mak, T.W. and Brenner, D. (2016) TNF and ROS Crosstalk in Inflammation. Trends in Cell Biology, 26, 249-261. [Google Scholar] [CrossRef] [PubMed]
[21] Morgan, M.J. and Liu, Z.G. (2010) Reactive Oxygen Species in TNFα-Induced Signaling and Cell Death. Molecules and Cells, 30, 1-12. [Google Scholar] [CrossRef] [PubMed]
[22] He, X., Song, Y., Wang, L. and Xu, J.M. (2019) Protective Effect of Pyrrolidine Dithiocarbamate on Isoniazid/ Rifampicininduced Liver Injury in Rats. Molecular Medicine Reports, 21, 463-469. [Google Scholar] [CrossRef] [PubMed]
[23] De La Barrera, S., Alemán, M., Musella, R., et al. (2004) IL-10 Down-Regulates Costimulatory Molecules on Mycobacterium tuberculosis-Pulsed Macrophages and Impairs the Lytic Activity of CD4 and CD8 CTL in Tuberculosis Patients. Clinical & Experimental Immunology, 138, 128-138. [Google Scholar] [CrossRef] [PubMed]
[24] Fortsch, D., Rollinghoff, M. and Stenger, S. (2000) IL-10 Converts Human Dendritic Cells into Macrophage-Like Cells with Increased Antibacterial Activity Against Virulent My-cobacterium tuberculosis. Journal of Immunology, 165, 978-987. [Google Scholar] [CrossRef] [PubMed]
[25] 周小博, 张荣臻, 陈湘榆, 吕超, 莫镜鄰, 毛德文. Th17细胞和Treg细胞在肝脏疾病中的作用研究进展[J]. 中国医药导报, 2019, 16(33): 23-27.